"Targeting a Key Protein to Halt Cancer Spread"

Scientists at the University of California, Riverside have developed a peptide compound that can bind to the shapeless protein MYC, which is implicated in 75% of human cancer cases, and help control its overactivity. This breakthrough could potentially lead to a way to stop cancer cells from spreading. The peptide, NT-B2R, was shown to successfully bind to MYC in tests using human brain cancer cells, ultimately decreasing the metabolism and proliferation of the cancer cells. While more research and testing are needed, this discovery offers promising potential for cancer drug development.